Analyze of long-term prognosis of coronary artery bypass grafting in patients with coronary atherosclerotic and chronic kidney disease

doi:10.3969/j.issn.1006-7795.2020.04.016

Abstract

Abstract: Objective To analyze the prognosis and factors of coronary artery bypass grafting (CABG) in patients with chronic kidney disease(CKD). Methods The clinical data of 1056 patients with chronic kidney disease who underwent CABG in Anzhen Hospital, Capital Medical University from January 2007 to December 2018 were collected,and the long-term follow-up were completed, which included basic perioperative information, surgical procedure, operative complication, and hospitalization costs. Results The level of preoperative creatinine was (184.56±145.93) mmol/L, estimated glomerular filtration rate(eGFR)was (34.57±12.61) mL·min^-1·1.73 m^-2,and the cases of phase 3 to 5 of CKD were 739, 226, and 91 patients, respectively. A total of 183 patients (17.3%) were diagnosed with left main stenosis. The average number of lesion vessels was 3.02±0.73, the proportion of off-pump CABG was 936 (88.6%), and the average graft number were 2.92±0.82. The mortality rate was 6.1% (64 case), and the incidence rate of acute kidney failure, reoperation for stanching, and perioperative myocardial infarction was 83(7.9%), 73(6.9%), and 134(12.7%), and 155(14.7%) respectively. The follow-up rate was 92.2% and the median follow-up time was 6 years (1-11 years). The long-term survival rate was 93.6%,74.7% patients occurred without major adverse cardiac and cerebrovascular events (MACCE), and 58 died from all-cause. Logistics regression analyze showed that the female, emergency surgery, dialysis, cerebral infarction history, and left main stenosis were positively correlated with perioperative death (P=0.039,0.037,0.020,0.009,0.000), whereas off-pump coronary bypass grafting (OPCABG) was negatively correlated with perioperative death (P=0.002). The dialysis history, higher level of triglyceride, and chronic obstructive pulmonary diseases (COPD) were independent risk factors of MACCE (P=0.016,0.003,0.031). Conclusion The risk of CABG procedure in patients with CKD was obviously high. The female, emergency surgery, dialysis, cerebral infarction history, and left main stenosis were independent risk factors of death, whilst OPCABG was protective factor. The dialysis history, higher level of triglyceride, and COPD were independent risk factors of MACCE.

Key words: coronary atherosclerotic heart disease, coronary artery bypass grafting, chronic kidney disease, major adverse cardiac and cerebrovascular events

CLC Number:

Li Yang, Dong Ran, Rui Hongliang, Liu Taoshuai, Zheng Jubing, Xu Xiaoyu, Zhao Yang, Song Bangrong, Zhang Kui. Analyze of long-term prognosis of coronary artery bypass grafting in patients with coronary atherosclerotic and chronic kidney disease[J]. Journal of Capital Medical University, 2020, 41(4): 597-602.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.04.016

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I4/597

References 32

[1]	Go A S, Chertow G M, Fan D,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization[J]. N Engl J Med,2004,351(13):1296-1305.
[2]	Charytan D M, Natwick T, Solid C A, et al. Comparative effectiveness of medical therapy, percutaneous revascularization, and surgical coronary revascularization in cardiovascular risk subgroups of patients with CKD:a retrospective cohort study of medicare beneficiaries[J]. Am J Kidney Dis,2019, 74(4):463-473.
[3]	Gennaro G, Mehran R, Serruys P W, et al. Left main revascularization with PCI or CABG in patients with chronic kidney disease, EXCEL Trial[J]. J Am Coll Cardiol, 2018,72(7):754-765.
[4]	Cooper W A, O'Brien S M, Thourani V H, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery:results from the Society of Thoracic Surgeons National Adult Cardiac Database[J]. Circulation, 2006,113(8):1063-1070.
[5]	Corredor C,Thomson R,Al-Subaie N.Long-term consequences of acute kidney injury after cardiac surgery:a systematic review and meta-analysis[J].J Cardiothorac Vasc Anesth,2016,30(1):69-75.
[6]	Gelsomino S, Bonacchi M, Lucà F,et al. Comparison between three different equations for the estimation of glomerular filtration rate in predicting mortality after coronary artery bypass[J]. BMC Nephrol, 2019,20(1):371.
[7]	Nakayama Y, Sakata R, Ura M, Itoh T, et al. Long-term results of coronary artery bypass grafting in patients with renal insufficiency[J]. Ann Thorac Surg,2003,75(2):496-500.
[8]	Hanna E B, Chen A Y, Roe M T, et al. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention[J]. JACC Cardiovasc Interv, 2011,4(9):1002-1008.
[9]	Kang S H, Lee C W, Yun S C, et al. Coronary artery bypass grafting vs. drug-eluting stent implantation for multivessel disease in patients with chronic kidney disease[J]. Korean Circ J,2017,47(3):354-360.
[10]	Polkinghorne K R. Controversies in chronic kidney disease staging[J]. Clin Biochem Rev,2011,32(2):55-59.
[11]	Serruys P W, Morice M C, Kappetein A P, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J]. N Engl J Med, 2009,360:961-972.
[12]	Farkouh M E, Domanski M, Sleeper L A, et al. Strategies for multivessel revascularization in patients with diabetes[J].N Engl J Med, 2012,367(25):2375-2384.
[13]	Cooper W A, O'Brien S M, Thourani V H, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery:results from the Society of Thoracic Surgeons National Adult Cardiac Database[J].Circulation,2006,113(8):1063-1070.
[14]	Lautamäki A, Kiviniemi T, Biancari F, et al. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease[J].Eur J Cardiothoracic Surg,2016,49(3):926-930.
[15]	Kim H J, Kim J B, Jung S H, et al. Coronary artery bypass grafting in patients with severe chronic kidney disease:a propensity score-weighted analysis on the impact of on-pump versus off-pump strategies[J]. Eur J Cardiothoracic Surg, 2017,52(5):937-944.
[16]	Lin T C, Lu T M, Huang F C et al. Coronary artery bypass surgery versus percutaneous coronary intervention for left main coronary artery disease with chronic kidney disease[J]. Int Heart J, 2018, 59(2):279-285.
[17]	Charytan D M, Yang S S, McGurk S, et al. Long- and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease[J]. Nephrol Dial Transplant,2010,25(11):3654-3663.
[18]	Wang Y, Zhu S, Gao P,et al. Off-pump versus on-pump coronary surgery in patients with chronic kidney disease:a meta-analysis[J]. Clin Exp Nephrol,2018,22(1):99-109.
[19]	Winkelmayer W C, Levin R, Avorn J. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery[J].Am J Kidney Dis, 2003,41(1):84-89.
[20]	Kilic A, Sultan I, Gleason T G, et al. Surgical versus percutaneous multivessel coronary revascularization in patients with chronic kidney disease[J]. Eur J Cardiothoracic Surg, 2020,57(5):994-1000.
[21]	Baber U, Farkouh M E, Arbel Y, et al. Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease[J]. Eur Heart J, 2016,37(46):3440-3447.
[22]	Ko W, Tranbaugh R, Marmur J D, et al. Myocardial revascularization in New York State:variations in the PCI-to-CABG ratio and their implications[J]. J Am Heart Assoc, 2012,1(2):e001446.
[23]	Epstein A J, Polsky D, Yang F, et al. Coronary revascularization trends in the United States, 2001-2008[J]. JAMA,2011,305(17):1769-1776.
[24]	Chang T I, Shilane D, Kazi D S, et al. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD[J]. J Am Soc Nephrol,2012,23(12):2042-2049.
[25]	Stallwood M I, Grayson A D, Mills K, et al. Acute renal failure in coronary artery bypass surgery:independent effect of cardiopulmonary bypass[J]. Ann Thorac Surg, 2004,77(3):968-972.
[26]	Chaudhry U A, Harling L, Rao C, et al. Off-pump versus on-pump coronary revascularization:meta-analysis of mid- and long-term outcomes[J]. Ann Thorac Surg, 2014,98(2):563-572.
[27]	Garg A X, Devereaux P J, Yusuf S, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery:a randomized clinical trial[J]. JAMA, 2014,311(21):2191-2198.
[28]	Boulton B J, Kilgo P, Guyton R A, et al. Impact of preoperative renal dysfunction in patients undergoing off-pump versus on-pump coronary artery bypass[J]. Ann Thorac Surg, 2011,92(2):595-601.
[29]	Lamy A, Devereaux P J, Prabhakaran D, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days[J]. N Engl J Med, 2012,366(16):1489-1497.
[30]	Dohi T, Miyauchi K, Okazaki S, et al. Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions[J]. Nephrol Dial Transplant, 2011,26(9):2906-2911.
[31]	Devbhandari M P, Duncan A J, Grayson A D, et al. Effect of riskadjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery:a multi-centre study[J]. Eur J Cardiothorac Surg,2006,29(6):964-970.
[32]	Zakeri R, Freemantle N, Barnett V, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting[J]. Circulation, 2005,112(9 Suppl):1270-1275.